Leena Setala
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Leena Setala has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Daiva Gudaviciene
Institute of Oncology, Vilnius University, Vilnius, Lithuania
2 shared publications- Pertti Lipponen
Department of Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland
2 shared publications A. Papp
1 shared publicationAri V. Uusaro
1 shared publicationE Alhava
Departments of Surgery and
1 shared publicationE M Alhava
1 shared publication
Latest Publications
- 1 May 2014
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 67 (5) , 676-681
Can the efficacy of reduction mammoplasty be predicted? The applicability and predictive value of breast-related symptoms questionnaire in measuring breast-related symptoms pre- and postoperatively
- 1 May 2014
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 67 (5) , 676-681
Can the efficacy of reduction mammoplasty be predicted? The applicability and predictive value of breast-related symptoms questionnaire in measuring breast-related symptoms pre- and postoperatively
- 11 June 2013
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 29 (08) , 505-510
Glucose and Lactate Metabolism in Well-Perfused and Compromised Microvascular Flaps
The success in microvascular flap transfer depends on the maintenance of optimal perfusion postoperatively. In addition to anastomosis thrombosis, other perfusion failures such as venous congestion, spasms, and kinks may appear. As perforator flaps become more frequent, it must be remembered that perforating vessels are more fragile and susceptible for trauma and mechanical compression. Sometimes, a flap is doing not well even though its anastomosis is patent. The flap perfusion can be measured using different tools in addition to clinical surveillance. We have used microdialysis in monitoring 268 microsurgical flaps and compared the metabolic data of normally perfused flaps to those that suffered from relative or absolute perfusion failure. We found that tissue glucose and lactate concentrations and especially their relation (lactate-to-glucose ratio) can show the presence of ischemia and aid in decision making, whether to reoperate or not. High lactate-to-glucose ratio may also predict total or partial flap necrosis.
- 11 June 2013
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 29 (08) , 505-510
Glucose and Lactate Metabolism in Well-Perfused and Compromised Microvascular Flaps
The success in microvascular flap transfer depends on the maintenance of optimal perfusion postoperatively. In addition to anastomosis thrombosis, other perfusion failures such as venous congestion, spasms, and kinks may appear. As perforator flaps become more frequent, it must be remembered that perforating vessels are more fragile and susceptible for trauma and mechanical compression. Sometimes, a flap is doing not well even though its anastomosis is patent. The flap perfusion can be measured using different tools in addition to clinical surveillance. We have used microdialysis in monitoring 268 microsurgical flaps and compared the metabolic data of normally perfused flaps to those that suffered from relative or absolute perfusion failure. We found that tissue glucose and lactate concentrations and especially their relation (lactate-to-glucose ratio) can show the presence of ischemia and aid in decision making, whether to reoperate or not. High lactate-to-glucose ratio may also predict total or partial flap necrosis.
- 22 September 2009
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 25 (09) , 521-526
Cost Analysis of 109 Microsurgical Reconstructions and Flap Monitoring with Microdialysis
Few studies have examined the cost-effectiveness of microsurgery, and little is known about the cost-effectiveness of flap monitoring. We studied the costs related to microsurgery during 2004 to 2006 in Kuopio University Hospital. A total of 99 patients were reconstructed with 109 flaps. Primary success was achieved in 64% of cases. Reoperation for anastomosis was conducted in 25% and for other surgical complications in 27%. The intended result was achieved in 94% of cases. The mean total cost of hospital care was 20,000 € in head and neck cancer surgery, 15,500 € in defects of the lower extremities, and 9200 € in breast reconstruction. The costs were greatly influenced by surgical complications (i.e., if the primary reconstruction failed, then the secondary microvascular flap almost doubled the expense involved; mean expenses per case 27,900 €). Microdialysis was used in flap monitoring with an additional cost of 535 € per patient. We found that microdialysis provided an early diagnosis of perfusion failure and helped to save the flap. It was estimated that if one or two flaps per year are saved due to more effective monitoring, then the extra costs of using microdialysis are covered.
- 22 September 2009
- Published by Georg Thieme Verlag KG in Journal of Reconstructive Microsurgery
- Vol. 25 (09) , 521-526
Cost Analysis of 109 Microsurgical Reconstructions and Flap Monitoring with Microdialysis
Few studies have examined the cost-effectiveness of microsurgery, and little is known about the cost-effectiveness of flap monitoring. We studied the costs related to microsurgery during 2004 to 2006 in Kuopio University Hospital. A total of 99 patients were reconstructed with 109 flaps. Primary success was achieved in 64% of cases. Reoperation for anastomosis was conducted in 25% and for other surgical complications in 27%. The intended result was achieved in 94% of cases. The mean total cost of hospital care was 20,000 € in head and neck cancer surgery, 15,500 € in defects of the lower extremities, and 9200 € in breast reconstruction. The costs were greatly influenced by surgical complications (i.e., if the primary reconstruction failed, then the secondary microvascular flap almost doubled the expense involved; mean expenses per case 27,900 €). Microdialysis was used in flap monitoring with an additional cost of 535 € per patient. We found that microdialysis provided an early diagnosis of perfusion failure and helped to save the flap. It was estimated that if one or two flaps per year are saved due to more effective monitoring, then the extra costs of using microdialysis are covered.
- 1 February 2009
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 62 (2) , 195-199
Obesity and complications in breast reduction surgery: are restrictions justified?
- 1 February 2009
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 62 (2) , 195-199
Obesity and complications in breast reduction surgery: are restrictions justified?
- 1 January 2004
- Published by Wiley in Microsurgery
- Vol. 24 (3) , 223-231
Glucose, lactate, and pyruvate response in an experimental model of microvascular flap ischemia and reperfusion: A microdialysis study
Early diagnosis of postoperative perfusion failure is essential in microsurgical tissue transfer. In order to determine if microdialysis could be used in diagnosing flap ischemia, we tested this method in an experimental pig model. Sixty‐six flaps (34 myocutaneous and 29 cutaneous) were created in 18 anesthetized pigs. During the experiment, secondary ischemia was induced for 5 h by selective clamping of the artery (20 flaps) or vein (21 flaps). Glucose, lactate, and pyruvate concentrations were measured hourly from the muscular and dermal layers. We found that decreasing glucose levels and increasing lactate concentrations were associated with arterial and venous occlusions from the first hour of ischemia. In venous ischemia, lactate concentrations remained lower than those in arterial ischemia. The increase in lactate‐to‐pyruvate and lactate‐to‐glucose ratios was related to ischemia and also discriminated arterial occlusion from venous occlusion. In conclusion, microdialysis can be used to facilitate early detection of ischemia.
- 1 January 2004
- Published by Wiley in Microsurgery
- Vol. 24 (3) , 223-231
Glucose, lactate, and pyruvate response in an experimental model of microvascular flap ischemia and reperfusion: A microdialysis study
Early diagnosis of postoperative perfusion failure is essential in microsurgical tissue transfer. In order to determine if microdialysis could be used in diagnosing flap ischemia, we tested this method in an experimental pig model. Sixty‐six flaps (34 myocutaneous and 29 cutaneous) were created in 18 anesthetized pigs. During the experiment, secondary ischemia was induced for 5 h by selective clamping of the artery (20 flaps) or vein (21 flaps). Glucose, lactate, and pyruvate concentrations were measured hourly from the muscular and dermal layers. We found that decreasing glucose levels and increasing lactate concentrations were associated with arterial and venous occlusions from the first hour of ischemia. In venous ischemia, lactate concentrations remained lower than those in arterial ischemia. The increase in lactate‐to‐pyruvate and lactate‐to‐glucose ratios was related to ischemia and also discriminated arterial occlusion from venous occlusion. In conclusion, microdialysis can be used to facilitate early detection of ischemia.
- 1 January 2001
- Published by Wiley in Histopathology
- Vol. 38 (1) , 13-20
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer
To study the controversial role of transmembrane glycoprotein CD44 as a moderator of tumour spread and as a prognostic factor in gastric cancer. The expression of all CD44 forms and that with exon v3 was assessed in 198 stage I-IV gastric adenocarcinomas using immunohistochemistry. CD44 expression was found in 72% and CD44v3 in 55% of the cases. The intensity of CD44 expression was associated with the level of invasion and with hyaluronan expression, while the frequency of CD44 positive cells was not significantly related to any of the clinical or histological features of the tumours. CD44v3 expression failed to show any association with the clinical or histological variables examined. Neither total CD44 nor CD44v3 expression affected survival. The most important prognostic factors in this cohort were the level of invasion, lymph node status, tumour size and vascular or perineural invasion. Changes in CD44 or CD44v3 expression level do not predict tumour spread or patient survival in gastric cancer.
- 1 January 2001
- Published by Wiley in Histopathology
- Vol. 38 (1) , 13-20
Expression of CD44 and its variant isoform v3 has no prognostic value in gastric cancer
To study the controversial role of transmembrane glycoprotein CD44 as a moderator of tumour spread and as a prognostic factor in gastric cancer. The expression of all CD44 forms and that with exon v3 was assessed in 198 stage I-IV gastric adenocarcinomas using immunohistochemistry. CD44 expression was found in 72% and CD44v3 in 55% of the cases. The intensity of CD44 expression was associated with the level of invasion and with hyaluronan expression, while the frequency of CD44 positive cells was not significantly related to any of the clinical or histological features of the tumours. CD44v3 expression failed to show any association with the clinical or histological variables examined. Neither total CD44 nor CD44v3 expression affected survival. The most important prognostic factors in this cohort were the level of invasion, lymph node status, tumour size and vascular or perineural invasion. Changes in CD44 or CD44v3 expression level do not predict tumour spread or patient survival in gastric cancer.
- 1 December 1997
- Vol. 19 (6)
Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
To assess the value of DNA ploidy and S-phase fraction (SPF) as prognostic factors in gastric cancer.
- 1 December 1997
- Vol. 19 (6)
Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer.
To assess the value of DNA ploidy and S-phase fraction (SPF) as prognostic factors in gastric cancer.